| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |